Role of CD137/4-1BB and its ligand in the NK cell mediated immune surveillance of acute myeloid leukemia.

被引:0
|
作者
Baessler, Tina [1 ]
Krusch, Matthias [1 ]
Baltz, Katrin M. [1 ]
Schmiedel, Benjamin J. [1 ]
Schmetzer, Helga M. [2 ]
Kanz, Lothar [1 ]
Salih, Helmut R. [1 ]
机构
[1] Univ Tubingen, Dept Hematol & Oncol, Tubingen, Germany
[2] Univ Munich, Dept Med 3, Munich, Germany
关键词
D O I
10.1182/blood.V110.11.880.880
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
880
引用
收藏
页码:269A / 269A
页数:1
相关论文
共 50 条
  • [31] 4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection
    Lee, SC
    Ju, SA
    Pack, HN
    Heo, SK
    Suh, JH
    Park, SM
    Choi, BK
    Kwon, BS
    Kim, BS
    INFECTION AND IMMUNITY, 2005, 73 (08) : 5144 - 5151
  • [32] The Role of CD137 and Its Ligand in Chronic Lymphocytic Leukemia (CLL)
    Baessler, Tina
    Buechele, Corina
    Krusch, Matthias
    Schmiedel, Benjamin J.
    Kanz, Lothar
    Salih, Helmut R.
    BLOOD, 2008, 112 (11) : 1073 - 1073
  • [33] Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4+ T cell-mediated inflammatory colitis
    Maerten, P
    Kwon, BS
    Shen, C
    De Hertogh, G
    Cadot, P
    Bullens, DMA
    Overbergh, L
    Mathieu, C
    Van Assche, G
    Geboes, K
    Rutgeerts, P
    Ceuppens, JL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 143 (02): : 228 - 236
  • [34] Clinical association of serum CD137 (4-1BB) levels in patients with systemic sclerosis
    Hamaguchi, Yasuhito
    Hasegawa, Minoru
    Matsushita, Takashi
    Komura, Kazuhiro
    Takehara, Kazuhiko
    Fujimoto, Manabu
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2009, 53 (02) : 159 - 161
  • [35] Role of 4-1BB (CD137) in the functional activation of cord blood CD28-CD8+ T cells
    Kim, YJ
    Brutkiewicz, RR
    Broxmeyer, HE
    BLOOD, 2002, 100 (09) : 3253 - 3260
  • [36] Targeting CD137 (4-1BB) towards improved safety and efficacy for cancer immunotherapy
    Liu, Guizhong
    Luo, Peter
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] Contribution of 4-1BB (CD137) costimulatory molecule to skin allograft rejection.
    Wolisi, G
    Srirangam, A
    Vinay, D
    Kwon, BS
    FASEB JOURNAL, 1999, 13 (05): : A661 - A661
  • [38] The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy
    Claus, Christina
    Ferrara-Koller, Claudia
    Klein, Christian
    MABS, 2023, 15 (01)
  • [39] 4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy
    Vinay, Dass S.
    Kwon, Byoung S.
    BMB REPORTS, 2014, 47 (03) : 122 - 129
  • [40] Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies
    Melero, Ignacio
    Murillo, Oihana
    Dubrot, Juan
    Hervas-Stubbs, Sandra
    Perez-Gracia, Jose L.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (08) : 383 - 390